Refractory Thyroid Cancer
1 clinical trials · Condition
◉ Watch Refractory Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer (NCT05733013) | Memorial Sloan Kettering Cancer Center | 2023-02-07 |
Track Refractory Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.